期刊文献+

蛋白酶抑制剂Lactacystin建立帕金森病大鼠模型的胶质细胞反应

The reaction of glial cells in the Parkinson' s rat model induced by proteinase inhibitor Lactacystin
在线阅读 下载PDF
导出
摘要 目的:探讨蛋白酶抑制剂造成的蛋白酶功能损伤的帕金森病(PD)动物模型黑质区胶质细胞的病理特点.方法:将SD大鼠随机分成3组:Lactacystin组、生理盐水组及正常对照组.使用立体定向注射方法向黑质区注射Lactacystin制作PD大鼠单侧模型.采用免疫组化方法观察大鼠黑质区酪氨酸羟化酶(TH)、胶质纤维酸性蛋白(GFAP)、植物凝集素(BSI-B4)免疫阳性细胞并对其进行细胞计数及灰度分析,对黑质区的多巴胺神经元、星形胶质细胞及小胶质细胞进行分析.结果:模型组病变侧黑质区TH阳性细胞较正常组和生理盐水组明显减少(P〈0.05),胞浆染色浅.GFAP免疫组化染色模型组灰度值较正常组及生理盐水组降低(P〈0.05).BSI-B4免疫组化染色模型组阳性细胞均数较正常组和生理盐水明显增加(P〈0.05);模型组灰度值较正常组及生理盐水组低(P〈0.05).结论:泛素蛋白酶抑制剂lactacystin可导致多巴胺能神经元变性死亡,并可导致黑质区小胶质细胞增生活化与星形胶质细胞的活化. Objective:To study the pathologic characteristics of the glial cells in the substantia nigra in rat model with Parkinson Disease (PD) induced by proteasome inhibitor. Methods: SD rats were randomly divided into 3 groups: the Lactacystin group, normal saline group and control group. Stereotaxic injection of Lactacystin into substantia nigra was used to establish unilateral PD rat model. Immunohistochemical stain were use to study the change of tyrosine hydroxylase (TH), glial fibrillary acidic protein (GFAP), and BSI-B4 induced positive cells in the substantia nigra region in rats, positive cell count and gradation analysis were performed; besides, dopamine neuron, astrocytes and microglia over substantia nigra region were also analyzed. Results: Compared with the control and normal saline group, the TH immunopositive cells decreased significantly ( P 〈 0.05 ) and endoehylema staining became shallower in the lesion lateral of the Lactacystin group ; the Gray-Scale in GFAP immunohistochemistry group was lower,and positive cell count in BSI-IM immunohistochemistry group increased significantly than that of the other two groups ( P 〈 0.05 ) ; the Gray-Scale analysis in model group was lower than that of physical saline group (P 〈 0. 05 ). Conclusion: Ubiquitin proteinase inhibitor Laetacystin may induce the degeneration of the dopaminergic neuron and might lead to activation of glial cells and astrocytes in the substantia nigra region.
出处 《广州医学院学报》 2010年第3期1-5,共5页 Academic Journal of Guangzhou Medical College
基金 广东省科技计划资助项目(2004B338010114)
关键词 帕金森病 泛素蛋白酶体系统 LACTACYSTIN 小胶质细胞 星型胶质细胞 动物模型 大鼠 Parkinson' s disease ubiquitin proteasome system Lactacystin microglia astroglia cell animal model, rats
  • 相关文献

参考文献17

  • 1Dehmer T,Lindenau J,Haid S,et al.Deficiency of Inducible nitric oxide synthase protects against MPTP toxicity in vivo[J].J Neurochem,2000,74(5):2213-2216.
  • 2Cicchetti F,Brownell AL,Williams K,et al.Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging[J].Eur J Neurosci,2002,15(6):991-998.
  • 3He Y,Appel S,Le WL.Minocyline inhibits microglial activation and protects nigral cell after 6-hydroxydopamine injection into mouse striatum1[J].Brain Res,2001,909(1-2):187-193.
  • 4Liberatore GT,Jackson-Lewis V,Vukosavic S,et al.Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease[J].Nat Med,1999,5(12):1403-1409.
  • 5Itzhak Y,Martin JL,Ali SF.Methamphetamine-and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitricoxide synthase-deficient mice[J].Synapse,1999,34(4):305-312.
  • 6Wu DC,Jackson-Lewis V,Vila M,et al.Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse modelof Parkinson disease[J].J Neurosci,2002,22(5):1763-1771.
  • 7张克忠,蒋雨平,丁新生.应用蛋白酶体抑制剂Lactacystin建立有Lewy体的帕金森病大鼠模型[J].临床神经病学杂志,2006,19(5):358-361. 被引量:10
  • 8Rideout HJ,Lang Rollin IC,Savalle M,et al.Dopaminergic neurons in rat ventralmidbrain cultures undergo selective apoptosis and form inclusions,but do not up2regulate iHSP70,following p roteasomal inhibition[J].J Neurochem,2005,93(5):1304-1313.
  • 9包新民 舒斯云.大鼠脑立体定向图谱[M].北京:人民卫生出版社,1991.48-60.
  • 10Dick LR,Cruikshank AA,Grenier L,et al.Mechanistic studies on the inactivation of the p roteasome by lactacystin:a central role forclastolactacystin beta-lactone[J].J Biol Chem,1996,271(13):7273-7276.

二级参考文献23

  • 1陆建明,周厚广,鲍远程,尤年兴,薛建中.左旋多巴对帕金森病大鼠毒性作用的实验研究[J].临床神经病学杂志,2004,17(5):354-356. 被引量:6
  • 2Fornai F,Lenzi P,Gesi M,et al.Fine structure and biochemical mechanisms underlying nigrostriatal inclusions and cell death after proteasome inhibition[ J ].J Neurosci,2003,23 (26):8955 -8966.
  • 3Rideout H J,Lang-Rollin IC,Savalle M,et al.Dopaminergic neurons in rat ventral midbrain cultures undergo selective apoptosis and form inclusions,but do not up-regulate iHSP70,following proteasomal inhibition[J].J Neurochem,2005,93(5):1304-1313.
  • 4McNaught KS,Mytilineou C,Jnobaptiste R,et al.Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures[ J ].J Neurochem,2002,81 (2):301 -306.
  • 5Shimura H,Hattori N,Kubo S,et al.Familial Parkinson disease gene product,parkin,is a ubiquitin-protein ligase[ J].Nat Genet,2000,25(3):302 -305.
  • 6Zhang Y,Gao J,Chung KK,et al.Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein,CDCrel-1[ J].Proc Natl Acad Sci USA,2000,97 (24):13354-13359.
  • 7McNaught KS,Jenner P.Proteasomal function is impaired in substantia nigra in Parkinson's disease[ J].Neurosci Lett,2001,297(3):191 -194.
  • 8Conway KA,Rochet JC,Bieganski RM,et al.Kinetic stabilization of the alpha -synuclein protofibril by a dopamine-alpha-synuclein adduct[J].Science,2001,294 (5545):1346-1349.
  • 9Sulzer D.alpha-synuclein and cytosolic dopamine:stabilizing a bad situation[ J].Nat Med,2001,7(12):1280-1282.
  • 10Stefanis L,Larsen KE,Rideout HJ,et al.Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system,loss of dopamine release,and autophagic cell death[ J].J Neurosci,2001,21(24):9549 -9560.

共引文献80

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部